3-D Conformal HDR Brachytherapy as Monotherapy for Localized Prostate Cancer

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Strahlentherapie und Onkologie (Print)

• Publication date

  2004-04-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1007/s00066-004-1215-4PMID 15057433
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vivo thermoluminescence dosimetry dose verification of transperineal 192Ir high-dose-rate brachytherapy using CT-based planning for the treatment of prostate cancer.

  2003cited by this paper
• Probability of late rectal morbidity in 125I prostate brachytherapy.

  2003cited by this paper
• [Physical and technical quality assurance and radiation protection in transperineal interstitial permanent prostate brachytherapy with 125-iodine seeds].

  2002cited by this paper
• High-Dose Rate Brachytherapy of Prostatic Adenocarcinoma in Combination with External Beam Radiotherapy

  2002cited by this paper
• Cancer Statistics, 2002

  2002cited by this paper
• [Recommendations for treatment with permanent, interstitial brachytherapy alone in locally limited prostate cancer].

  2002cited by this paper
• High-dose rate brachytherapy of prostatic adenocarcinoma in combination with external beam radiotherapy a long-term follow-up of the first 50 patients at one center.

  2002cited by this paper
• Physikalisch-technische Qualitätssicherung und Strahlenschutz bei der Monotherapie der Prostata mit Jod-125-Seeds

  2002cited by this paper
• Long-term outcome after elective irradiation of the pelvic lymphatics and local dose escalation using high-dose-rate brachytherapy for locally advanced prostate cancer.

  2002cited by this paper
• 10-year biochemical (prostate-specific antigen) control of prostate cancer with (125)I brachytherapy.

  2001cited by this paper
• Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: a feasibility report.

  2001influential reference
• A comprehensive review of CT-based dosimetry parameters and biochemical control in patients treated with permanent prostate brachytherapy.

  2001cited by this paper
• Postimplant dosimetry for (125)I prostate implants: definitions and factors affecting outcome.

  2000cited by this paper
• 3D Interstitial HDR Brachytherapy Combined with 3D External Beam Radiotherapy and Androgen Deprivation for Prostate Cancer Preliminary Results

  2000cited by this paper
• High dose rate prostate brachytherapy: the California Endocurietherapy (CET) method.

  2000cited by this paper
• Interim report of image-guided conformal high-dose-rate brachytherapy for patients with unfavorable prostate cancer: the William Beaumont phase II dose-escalating trial.

  2000cited by this paper
• Postimplant analysis of transperineal interstitial permanent prostate brachytherapy: evidence for a learning curve in the first year at a single institution.

  2000cited by this paper
• High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: treatment description and preliminary results of a phase I/II clinical trial.

  2000cited by this paper
• American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer.

  1999cited by this paper
• Ten‐year disease free survival after transperineal sonography‐guided iodine‐125 brachytherapy with or without 45‐gray external beam irradiation in the treatment of patients with clinically localized, low to high gleason grade prostate carcinoma

  1999cited by this paper
• Prostate preservation by combined external beam and HDR brachytherapy in nodal negative prostate cancer

  1999cited by this paper
• [Combined treatment of localized prostate cancer with HDR-Iridium 192 remote brachytherapy and external beam irradiation].

  1999cited by this paper
• New interstitial HDR brachytherapy technique for prostate cancer: CT based 3D planning after transrectal implantation.

  1999cited by this paper
• CT-Based Interstitial HDR Brachytherapy

  1999cited by this paper
• Die kombinierte Behandlung des lokal begrenzten Prostatakarzinoms mit HDR-Iridium-192-Nachlade-Brachytherapie und perkutaner Bestrahlung

  1999cited by this paper
• Edema associated with I-125 or Pd-103 prostate brachytherapy and its impact on post-implant dosimetry: an analysis based on serial CT acquisition.

  1998cited by this paper
• A dose-response study for I-125 prostate implants.

  1998cited by this paper
• High-dose rate interstitial with external beam irradiation for localized prostate cancer--results of a prospective trial.

  1998cited by this paper
• Correlation of medical dosimetry quality indicators to the local tumor control in patients with prostate cancer treated with iodine-125 interstitial implants.

  1998cited by this paper
• Source placement error for permanent implant of the prostate.

  1997cited by this paper
• Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update.

  1997cited by this paper
• Irradiation of localized prostatic carcinoma with a combination of high dose rate iridium-192 brachytherapy and external beam radiotherapy with three target definitions and dose levels inside the prostate gland.

  1997cited by this paper
• Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy.

  1995influential reference
• Patterns of care for carcinoma of the prostate gland: results of a national survey of 1984 and 1990.

  1995cited by this paper

• Interstitial High-Dose-Rate Brachytherapy Combined with External Beam Radiation Therapy for Dose Escalation in the Primary Treatment of Locally Advanced, Non-Resectable Superior Sulcus (Pancoast) Tumors: Results of a Monocentric Retrospective Study

  2024cites this paper
• Alterations of Sexual and Erectile Functions after Brachytherapy for Prostate Cancer Based on Patient-Reported Questionnaires

  2024cites this paper
• High Dose Rate Prostate Brachytherapy

  2021cites this paper
• High-Dose-Rate Brachytherapy as Monotherapy for Low- and Intermediate-Risk Prostate Cancer. Oncological Outcomes After a Median 15-Year Follow-Up

  2021cites this paper
• High-dose-rate brachytherapy as monotherapy for low- and intermediate-risk prostate cancer: long-term experience of Swedish single-center

  2021cites this paper
• Dose Escalation with High Dose Rate Brachytherapy or Protons in Curative Radiotherapy of Prostate Cancer

  2018cites this paper
• High-Dose-Rate Brachytherapy as Monotherapy for Prostate Cancer

  2018cites this paper
• Study of the correlation between rectal wall in vivo dosimetry performed with MOSkins and implant modification during TRUS-guided HDR prostate brachytherapy

  2017cites this paper
• In vivo dosimetry with alanine/electron spin resonance dosimetry to evaluate the urethra dose during high-dose-rate brachytherapy.

  2017cites this paper
• In vivo rectal wall measurements during HDR prostate brachytherapy with MOSkin dosimeters integrated on a trans-rectal US probe: Comparison with planned and reconstructed doses.

  2016cites this paper
• Genintourinary Oncology Intraoperative ultrasound-based planning can effectively replace postoperative CT-based planning for high-dose-rate brachytherapy for prostate cancer

  2016cites this paper
• Prostate: High-Dose Rate Brachytherapy in the Treatment of Clinically Organ-Confined Prostate Cancer

  2016cites this paper
• Intraoperative ultrasound-based planning can effectively replace postoperative CT-based planning for high-dose-rate brachytherapy for prostate cancer.

  2016cites this paper
• Outcomes of hypofractionated stereotactic body radiotherapy boost for intermediate and high-risk prostate cancer

  2016cites this paper
• High-dose-rate interstitial brachytherapy as monotherapy in one fraction for the treatment of favorable stage prostate cancer: Toxicity and long-term biochemical results.

  2016cites this paper
• Dosimetric comparison between treatment plans of patients treated with low-dose-rate vs. high-dose-rate interstitial prostate brachytherapy as monotherapy: Initial findings of a randomized clinical trial.

  2016cites this paper
• Dose-Escalated Robotic SBRT for Stage I–II Prostate Cancer

  2015cites this paper
• Protein O-mannosylation is crucial for human mesencyhmal stem cells fate

  2015cites this paper
• Identification and functional analysis of olfactory receptor family reveal unusual characteristics of the olfactory system in the migratory locust

  2015cites this paper
• Governance and functionality of community water schemes in rural Ethiopia

  2015cites this paper
• Additional androgen deprivation makes the difference

  2015cites this paper
• Ultrasound and Pet-Ct Image Fusion for Prostate Brachytherapy Image Guidance

  2015cites this paper
• Repression of somatic cell fate in the germline

  2015cites this paper
• Monotherapeutic high-dose-rate brachytherapy for prostate cancer: a dose reduction trial.

  2014cites this paper
• Thyroid Monitoring for Residents of Disaster-affected and Neighboring Areas

  2014cites this paper
• Stereotactic body radiotherapy for organ-confined prostate cancer

  2014cites this paper
• Asymmetric dose-volume optimization with smoothness control for rotating-shield brachytherapy.

  2014cites this paper
• A review of safety, quality management, and practice guidelines for high-dose-rate brachytherapy: executive summary.

  2014cites this paper
• High-dose-rate brachytherapy as monotherapy for prostate cancer: technique, rationale and perspective

  2014cites this paper
• Response to Drs Rogers, Hayes, and Demanes.

  2014cites this paper
• Treatment plan optimization for rotating-shield brachytherapy

  2014cites this paper
• Dosiseskalierte Strahlentherapie bei Patienten mit nicht- metastasiertem Prostatakarzinom: Klinische Anwendung, Tumorkontrolle und Nebenwirkungen

  2014cites this paper
• High-dose-rate interstitial brachytherapy in combination with androgen deprivation therapy for prostate cancer

  2014cites this paper
• High-Dose-Rate Brachytherapy in the Treatment of Clinically Localized Prostate Cancer

  2014cites this paper
• High-dose-rate interstitial brachytherapy as monotherapy for clinically localized prostate cancer: treatment evolution and mature results.

  2013cites this paper
• High-Dose-Rate Interstitial Brachytherapy as Monotherapy in One Fraction for the Treatment of Favorable Stage Prostate Cancer

  2013cites this paper
• Early quality of life outcomes in patients with prostate cancer managed by high‐dose‐rate brachytherapy as monotherapy

  2013cites this paper
• The emerging role of high-dose-rate (HDR) brachytherapy as monotherapy for prostate cancer

  2013cites this paper
• Prostate Brachytherapy: High Dose Rate

  2013cites this paper
• Hypofractionated SBRT versus conventionally fractionated EBRT for prostate cancer: comparison of PSA slope and nadir

  2013cites this paper
• Modern Brachytherapy in the Treatment of Prostate Cancer

  2013cites this paper
• Low-dose-rate or high-dose-rate brachytherapy in treatment of prostate cancer – between options

  2013cites this paper
• Brachytherapy in the therapy of prostate cancer – an interesting choice

  2013influential citation
• Results of HDR Prostate Brachytherapy Treatments

  2013cites this paper
• High-dose-rate brachytherapy for prostate cancer in a previously radiated patient with polyethylene glycol hydrogel spacing to reduce rectal dose: case report and review of the literature.

  2013cites this paper
• Focal high-dose-rate brachytherapy: a dosimetric comparison of hemigland vs. conventional whole-gland treatment.

  2013cites this paper
• High-dose-rate brachytherapy alone for localized prostate cancer in patients at moderate or high risk of biochemical recurrence.

  2012cites this paper
• Gold marker displacement due to needle insertion during HDR-brachytherapy for treatment of prostate cancer: A prospective cone beam computed tomography and kilovoltage on-board imaging (kV-OBI) study

  2012cites this paper
• Role of high dose rate brachytherapy in the treatment of prostate cancer.

  2012cites this paper
• High dose rate prostate brachytherapy: an overview of the rationale, experience and emerging applications in the treatment of prostate cancer.

  2012cites this paper
• Assessment of daily needle applicator displacement during high-dose-rate interstitial brachytherapy for prostate cancer using daily CT examinations.

  2012cites this paper
• Preimplant factors affecting prostate D90 after transperineal interstitial prostate brachytherapy with loose (125)I seeds.

  2012cites this paper
• High-dose-rate interstitial brachytherapy as monotherapy in one fraction and transperineal hyaluronic acid injection into the perirectal fat for the treatment of favorable stage prostate cancer: treatment description and preliminary results.

  2012cites this paper
• High-dose-rate brachytherapy as a monotherapy for favorable-risk prostate cancer: a Phase II trial.

  2012cites this paper
• Clinical Applications of High-Dose-Rate Brachytherapy

  2011cites this paper
• Advantage of robotic needle placement on a prostate model in HDR brachytherapy

  2011cites this paper
• Phase I dose-escalation study of stereotactic body radiation therapy for low- and intermediate-risk prostate cancer.

  2011cites this paper
• Computed Tomography-Guided Interstitial High-Dose-Rate Brachytherapy in the Local Treatment of Primary and Secondary Intrathoracic Malignancies

  2011cites this paper
• Image guided, adaptive, accelerated, high dose brachytherapy as model for advanced small volume radiotherapy.

  2011cites this paper
• Monotherapeutic high-dose-rate brachytherapy for prostate cancer: five-year results of an extreme hypofractionation regimen with 54 Gy in nine fractions.

  2011cites this paper
• Assessment of normal tissue complications following prostate cancer irradiation: comparison of radiation treatment modalities using NTCP models.

  2010cites this paper
• Needle applicator displacement during high-dose-rate interstitial brachytherapy for prostate cancer.

  2010cites this paper
• Evaluation of normal tissue complication probability and risk of second primary cancer in prostate radiotherapy.

  2010cites this paper
• Preimplant factors affecting postimplant CT-determined prostate volume and the CT/TRUS volume ratio after transperineal interstitial prostate brachytherapy with 125I free seeds

  2010cites this paper
• 14 – High Dose Rate Brachytherapy

  2010cites this paper
• Strahlentherapie des Prostatakarzinoms in der neuen S3-Leitlinie

  2010cites this paper
• Toxicity and early treatment outcomes in low- and intermediate-risk prostate cancer managed by high-dose-rate brachytherapy as a monotherapy.

  2009cites this paper
• Dynamic MRI and CAD vs. Choline MRS: Where is the detection level for a lesion characterisation in prostate cancer?

  2009cites this paper
• Correlation between dosimetric parameters and late rectal and urinary toxicities in patients treated with high-dose-rate brachytherapy used as monotherapy for prostate cancer.

  2009cites this paper
• HDR monotherapy for prostate cancer: a simulation study to determine the effect of catheter displacement on target coverage and normal tissue irradiation.

  2009cites this paper
• A Dosimetric Selectivity Intercomparison of HDR Brachytherapy, IMRT and Helical Tomotherapy in Prostate Cancer Radiotherapy

  2009cites this paper
• Current status and perspectives of brachytherapy for prostate cancer

  2009cites this paper
• Risk of second primary cancer following prostate cancer radiotherapy: DVH analysis using the competitive risk model

  2009cites this paper
• Extreme hypofractionation for prostate cancer

  2009cites this paper
• The impact of prostate volume changes during external-beam irradiation in consequence of HDR brachytherapy in prostate cancer treatment

  2009cites this paper
• Use of Gold Markers for Setup in Image-Guided Fractionated High-Dose-Rate Brachytherapy as a Monotherapy for Prostate Cancer

  2009cites this paper
• Brachytherapy for Prostate Cancer: A Systematic Review

  2009cites this paper
• Improving high dose rate and pulsed dose rate prostate brachytherapy : alternative prostate definition and treatment delivery verification methods

  2009cites this paper
• HDR prostate monotherapy: dosimetric effects of implant deformation due to posture change between TRUS- and CT-imaging.

  2008cites this paper
• Anniversary paper: past and current issues, and trends in brachytherapy physics.

  2008cites this paper
• High-dose-rate brachytherapy in the curative treatment of patients with localized prostate cancer.

  2008cites this paper
• Radiotherapy treatment delays and their influence on tumour control achieved by various fractionation schedules.

  2008cites this paper
• CT-Guided Interstitial Brachytherapy of Primary and Secondary Lung Malignancies

  2008cites this paper
• Real-time brachytherapy for prostate cancer – implant analysis

  2008cites this paper
• Prostate Cancer: Radiation therapy

  2008cites this paper
• Effects of Irradiation on the [Methyl-3H]Choline Uptake in the Human Prostate Cancer Cell Lines LNCaP and PC3

  2008cites this paper
• Virtual HDR CyberKnife treatment for localized prostatic carcinoma: dosimetry comparison with HDR brachytherapy and preliminary clinical observations.

  2008cites this paper
• A Phase II study of high-dose-rate afterloading brachytherapy as monotherapy for the treatment of localized prostate cancer.

  2008cites this paper
• Three-dimensional endoluminal ultrasound-guided interstitial brachytherapy in patients with anal cancer

  2008cites this paper
• Reirradiation for Recurrent Neck Metastases of Head-and-Neck Tumors Using CT-Guided Interstitial 192Ir HDR Brachytherapy

  2007cites this paper
• High-Dose-Rate Brachytherapy for Small-Sized Peripherally Located Lung Cancer

  2006cites this paper
• Der Einfluss palliativer Strahlentherapie auf Schmerz und Lebensqualität bei Patienten mit Knochenmetastasen

  2006cites this paper
• [Pain and quality of life following palliative radiotherapy of bone metastases].

  2006cites this paper
• Integration of IMRT and Brachytherapy

  2006cites this paper
• Evaluation of Possible Prostate Displacement Induced by Pressure Applied during Transabdominal Ultrasound Image Acquisition

  2006cites this paper
• Transperineal Permanent Seed Implantation of “Low-Risk” Prostate Cancer

  2006cites this paper
• Early intestinal changes following abdominal radiotherapy comparison of endpoints.

  2006cites this paper
• Dose-volume impact in high-dose-rate Iridium-192 brachytherapy as a boost to external beam radiotherapy for localized prostate cancer--a phase II study.

  2006cites this paper
• Changes of Dose Delivery Distribution within the First Month after Permanent Interstitial Brachytherapy for Prostate Cancer

  2006cites this paper
• High-dose-rate brachytherapy without external beam irradiation for locally advanced prostate cancer.

  2006cites this paper